Jennifer Panganiban, MD

faculty photo
Associate Professor of Clinical Pediatrics (Gastroenterology, Hepatology and Nutrition)
Medical Director, Metabolic dysfunction Associated Steatotic Liver Disease, Children's Hospital of Philadelphia
Medical Director, Nutrition Support Service, Children's Hospital of Philadelphia
Director Nutrition Fellowship, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of GI, Hepatology and Nutrition
34th and Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-590-3630
Fax: 215-590-3606
Email: panganibaj@chop.edu
Links
GLP-1RAs improve ALT in pediatric MASLD, could be ‘powerful option’ for some patients
NASPGHAN Webinar on MASLD
Experts Recommend Medication for Pediatric MASLD Management
Experts Recommend Medication for Pediatric MASLD Management
Healio coverage on GLP 1 RA work on Pediatric MASLD
NAFLD PAGE
CHOP Study: The Impact of Receptor Agonists on Pediatric MASLD
International NASH Day Press
International NASH day 2021
NAFLD program page
Education:
BS (Biology)
University of Santo Tomas, Manila, Philippines, 2001.
 MD
University of Santo Tomas, Manila, Philippines, 2005.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

https://www.chop.edu/centers-programs/non-alcoholic-fatty-liver-disease-clinic
https://www.chop.edu/conditions-diseases/non-alcoholic-fatty-liver-disease-nafld
https://www.chop.edu/news/childrens-hospital-philadelphia-celebrates-nashday

Description of Research Expertise

Introduction to Pediatric NAFLD Series - Panganiban - 2021 - Clinical Liver Disease - Wiley Online Library https://doi.org/10.1002/cld.1036
https://www.chop.edu/news/chop-study-impact-receptor-agonists-pediatric-masld
https://www.medscape.com/viewarticle/experts-recommend-medication-pediatric-masld-management-2025a10009vc

Selected Publications

Anam Bashir, Maria Mascarenhas, Jennifer Panganiban: Chapter: Parenteral Nutrition. Wyllie, Pediatric Gastrointestinal and Liver Disease 7th edition. Elsevier, Jun 2025.

 Hartmann P, Mouzaki M, Hassan S, Kehar M, Mysore KR, Mauney E, Nonga D, Karjoo S, Sood S, Tou A, Brichta C, Herdes RE, Pai N, Garner DK, Rinella ME, Noureddin M, Younossi Z, Allen A, Sanyal A, Kohut T, Kohli R, Ramirez CM, Xanthakos S, Vos MB, Schwimmer JB, Ibrahim SH, Panganiban J. : Call to action - pediatric MASLD requires immediate attention to curb health crisis. Hepatology 10(1097), Jun 2025.

 Panganiban J, Kehar M, Ibrahim SH, Hartmann P, Sood S, Hassan S, Ramirez CM, Kohli R, Censani M, Mauney E, Cuda S, Karjoo S. : Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025. Obesity Pillars 14(100164), Feb 2025.

 Andrea Tou, Panganiban J: GLP-1 Receptor Agonists have a potential to improve Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease. Poster, Emerging Topic Conference: MASLD, MetALD and ALD: Challenges and Opportunities, Las Vegas, NV Feb 2025.

 Abu- Alreesh, S, Panganiban J: Microbially derived volatile metabolites in Pediatric MASLD. Oral abstract, 7th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition Dec 2024.

 Tou, Andrea, Panganiban J: GLP-1 Receptor Agonists have a potential to improve disease activity in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease. Poster, 7th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition Dec 2024.

 Kohut T, Tou A, Carr E, Xanthakos S, Arce-Clachar AC, Fawaz R, Valentino PL, Panganiban J, Mouzaki M.: Topiramate treatment of pediatric metabolic dysfunction-associated steatotic liver disease: A descriptive cohort study. J Parenter Enteral Nutr. 49(3): 308-313, Dec 2024.

 Andrea Tou, Rima Fawaz, Emily Carr, Pamela Valentino, Ana Arce-Clachar, Marialena Mouzaki, Jennifer Panganiban, Taisa Kohut: Topiramate: A possible therapeutic option for Pediatric MASLD. Oral abstract, North American Society For Pediatric Gastroenterology, Hepatology & Nutrition National Conference Nov 2024.

 Andrea Tou and Jennifer Panganiban: GLP-1 Receptor Agonists have a potential to improve disease activity in Pediatric Metabolic Dysfunction-Associated Steatotic Liver Disease. Oral Abstract, American Association for the Study of Liver Diseases (AASLD)Liver Meeting Nov 2024.

 Sarah Abu- Alreesh MD, Amalia Berna, PhD, Audrey John and Jennifer Panganiban: Microbially derived volatile metabolites in pediatric MASLD. Oral Abstract,North American Society For Pediatric Gastroenterology, Hepatology & Nutrition National Conference Nov 2024.
back to top
Last updated: 07/21/2025
The Trustees of the University of Pennsylvania